Actively Recruiting
Provider Support and Patient Outreach in Lung Cancer Screening to Improve Screening Rates and Shared Decision Making
Led by Ronald Myers · Updated on 2026-05-29
822
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
R
Ronald Myers
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating whether providing education and counseling can improve lung cancer screening rates among patients with a history of smoking. This trial aims to assess the impact of these interventions on screening completion and shared decision making. It also seeks to understand factors influencing screening and barriers to implementing the educational program. The study uses a 2x2 cluster randomized design involving primary care practices and their providers, who are assigned to either receive support and educational activities or usual care. Patients within these practices are also randomized to receive educational outreach with counseling or usual care. Activities include online training, shared decision making counseling, surveys, and electronic health record reviews. Participants will complete surveys and may undergo educational sessions and counseling remotely. Researchers will monitor lung cancer screening completion within four months, referrals for screening and tobacco cessation over five years, repeat annual screenings, and follow-up diagnostics after abnormal results. The study involves baseline and endpoint assessments and aims to track outcomes up to five years.
CONDITIONS
Brief Title
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Primary care practice (family medicine, geriatrics, internal medicine) in one of the 4 participating health systems
- Practice uses the main electronic medical record of the system to run patient recruitment reports
- At least 50% of practice providers agree to participate
- Patient has a scheduled office or telemedicine visit with a participating primary care provider within 14 to 25 days
- Patient is between 50 and 77 years old
- Patient has at least a 20-pack-year smoking history
- Patient currently smokes or quit within the past 15 years
- Patient can communicate in English or Spanish
You will not qualify if you...
- Patient had any lung CT or low-dose CT scan in the past 11 months
- Patient has a prior history of lung cancer
- Patient was hospitalized within the last 60 days
- Patient has a diagnosis of dementia recorded in their medical records
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or telemedicine)
Duration - Up to 5 years
Participants undergo educational activities and shared decision making counseling as part of the intervention or receive usual care. Surveys are completed at baseline and end of study. Electronic health records are reviewed for lung cancer screening and related referrals.
Baseline and end-of-study surveys; educational activity and counseling occur once on study
Trial Site Locations
Total: 1 location
1
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107
Actively Recruiting
Research Team
R
Ronald Myers, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
SCREENING
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here